Auswahl der wissenschaftlichen Literatur zum Thema „Heart Diseases Prevention“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Heart Diseases Prevention" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Heart Diseases Prevention":
Shaukatovna, Ismatova Marguba. „PREVENTION AND DIAGNOSIS OF CIRCULATORY DISEASES IN OLD AGE“. American Journal of Medical Sciences and Pharmaceutical Research 04, Nr. 03 (01.03.2022): 56–58. http://dx.doi.org/10.37547/tajmspr/volume04issue03-11.
Kulmane, Edite, Mara Pilmane und Romans Lacis. „Apoptosis, ANUP, Chromogranin A, PGP 9.5, Endothelins and VEGF in Acquired Heart Diseases: Review of Literature“. Acta Chirurgica Latviensis 15, Nr. 1 (01.04.2015): 63–72. http://dx.doi.org/10.1515/chilat-2016-0012.
Asthana, Alok Kumar, Monika Asthana und Payal Sharma. „PREVENTION OF CARDIO VASCULAR DISEASE THROUGH AYURVEDA“. Asian Journal of Pharmaceutical Research and Development 6, Nr. 4 (23.08.2018): 97–100. http://dx.doi.org/10.22270/ajprd.v6i4.379.
Matuz-Mares, Deyamira, Héctor Riveros-Rosas, María Magdalena Vilchis-Landeros und Héctor Vázquez-Meza. „Glutathione Participation in the Prevention of Cardiovascular Diseases“. Antioxidants 10, Nr. 8 (29.07.2021): 1220. http://dx.doi.org/10.3390/antiox10081220.
Haque, KMHS Sirajul. „Prevention of Rheumatic Fever and Rheumatic Heart Diseases in Bangladesh“. Cardiovascular Journal 11, Nr. 2 (27.02.2019): 91–92. http://dx.doi.org/10.3329/cardio.v11i2.40407.
Ermakova, M. A., und A. Yu Pinigina. „Genetic studies in multifactorial diseases“. Glavvrač (Chief Medical Officer), Nr. 12 (10.12.2022): 36–40. http://dx.doi.org/10.33920/med-03-2212-06.
Sirota, N. A., O. V. Sivakova und V. M. Yaltonsky. „Dynamics of Risk Factors of Heart Diseases Under Influence of Remote Medical-Psychological Consulting“. Консультативная психология и психотерапия 27, Nr. 3 (2019): 175–96. http://dx.doi.org/10.17759/cpp.2019270311.
Lüscher, Thomas F. „Prevention of non-communicable diseases and special causes of heart failure“. European Heart Journal 36, Nr. 31 (14.08.2015): 2019–22. http://dx.doi.org/10.1093/eurheartj/ehv303.
Passarella, G., G. Trifirò, M. Gasparetto, G. Svaluto Moreolo und O. Milanesi. „Disorders in Glucidic Metabolism and Congenital Heart Diseases: Detection and Prevention“. Pediatric Cardiology 34, Nr. 4 (15.11.2012): 931–37. http://dx.doi.org/10.1007/s00246-012-0577-0.
Stewart, Bernard W., und Alan S. Coates. „Cancer Prevention: A Global Perspective“. Journal of Clinical Oncology 23, Nr. 2 (10.01.2005): 392–403. http://dx.doi.org/10.1200/jco.2005.05.132.
Dissertationen zum Thema "Heart Diseases Prevention":
Neubeck, Alicia Helen. „Increasing access to secondary prevention of cardiovascular disease“. Thesis, The University of Sydney, 2011. https://hdl.handle.net/2123/27329.
李雯靜 und Man-ching Anney Lee. „Effects of the disease management programme with nurse-led heart failure clinic“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B40721036.
Masoud, Mohamed Abdulsalam. „Validation of a recently proposed equation for the estimation of small, dense LDL particles from routine lipid measures in a population of mixed ancestry South Africans“. Thesis, Cape Peninsula University of Technology, 2016. http://hdl.handle.net/20.500.11838/2490.
Cardiovascular diseases (CVD) are the leading cause of global mortality, of which over 75% occurred in low- and middle-income countries such as South Africa. The lipid profile, specifically decreased levels of high density lipoprotein cholesterol (HDL-C), elevated triglyceride levels and the presence of small-dense low density lipoprotein (sdLDL) has been reported associated with CVD. An increased number of sdLDL is also common in metabolic syndrome (MetS), visceral obesity and diabetes mellitus, the last a known risk factor for CVD. The modification of low density lipoprotein (LDL) size, or number of sdLDL particles, has been reported to significantly reduce CVD risk, but not conclusively so and needs further investigation. In this regard, sdLDL particles are seldom estimated routinely for clinical use because of financial and other limitations. Currently, an alternative approach for estimating sdLDL is to use equations derived from routine lipid measures, as has been proposed by several groups. However, there is a need for extensive evaluation of this equation across different ethnic and disease groups, especially since reports showed an inadequate performance of the equation in a Korean population. The aim of this study was to assess the performance of a recently proposed equation for the estimation of sdLDL in healthy and diabetic mixed ancestry South Africans. Furthermore, we also investigated the role of sdLDL as a cardiometabolic risk factor, as measured against known risk factors such as the glycemic and lipid profiles.
Aachi, Venkat Raghav. „Preliminary Characterization of Mitochondrial ATP-sensitive Potassium Channel (MitoKATP) Activity in Mouse Heart Mitochondria“. PDXScholar, 2009. https://pdxscholar.library.pdx.edu/open_access_etds/1667.
Purdum, Michael B. „The Effects of Positive Emotion, Negative Emotion, Flourishing, and Languishing on Cardiovascular Risk“. Thesis, University of North Texas, 2010. https://digital.library.unt.edu/ark:/67531/metadc30503/.
Green, Kerrie L. „A descriptive analysis of cardiac rehabilitation education programs“. Virtual Press, 2000. http://liblink.bsu.edu/uhtbin/catkey/1177976.
Department of Physiology and Health Science
Strath, Scott J. „The effect of a light-moderate versus hard exercise intensity on health and fitness benefits“. Virtual Press, 1998. http://liblink.bsu.edu/uhtbin/catkey/1115726.
School of Physical Education
Bursill, Christina. „Green tea and its catechins modulate cholesterol metabolism in cultured human liver (HepG2) cells and the hypercholesterolaemic rabbit“. Title page, contents and introduction only, 2000. http://web4.library.adelaide.edu.au/theses/09PH/09pdb9725.pdf.
George, Siddiqah. „A critical analysis of mitochondrial functioning and associated proteins in obesity-related cardiomyopathy“. Thesis, Stellenbosch : Stellenbosch University, 2013. http://hdl.handle.net/10019.1/80377.
ENGLISH ABSTRACT: INTRODUCTION: The mechanism behind obesity-related cardiomyopathies is at present not completely known, however, cardiac insulin resistance has been implicated as one of the main arbitrators of obesity-related cardiovascular disease. A few studies have associated perturbations in the insulin-mediated PI3K/PKB/Akt pathway in mediating this insulin resistance. Moreover, this pathway has been shown to regulate myocardial apoptosis, which in turn has been implicated in a number of cardiovascular diseases. Currently, few studies have compared the early onset and advanced effects of obesity on the heart. AIMS: To compare the early and advanced stages of obesity in terms of myocardial (i) PI3K/PKB/Akt signalling, (ii) apoptotic signalling and (iii) mitochondrial integrity. Furthermore, we aim to assess the cardiac mitochondrial (i) PI3K/PKB/Akt signalling, (ii) apoptotic signalling and (iii) integrity during the advanced stages of obesity. METHODS: Male Wistar rats were randomly assigned to either a control or diet-induced obesity (DIO) group. Controls were fed a standard rat chow diet and the DIO group fed a high caloric diet (standard rat chow supplemented with sucrose and condensed milk). The diets were implemented for either 8 or 20 weeks and thereafter, the body weight, intra-peritoneal fat mass, and fasting blood glucose and insulin levels (including intra-peritoneal glucose tolerance tests (IPGTTs)) were determined. Freeze-clamped hearts from both groups were subjected to cytosolic western blot analysis for PI3K p85 subunit, PKB/Akt, GSK-3α/β, Bad, Bax and Bcl-2. A fraction of each heart was also subjected to WB analysis of the mitochondrial electron transport chain (ETC) complexes (I-V). Thereafter, the above mentioned proteins were also probed for in mitochondria isolated from the 20 weeks group after administering insulin and exposing the hearts to ischemia. Oxidative phosphorylation (OXPHOS) capacity analysis was then conducted on mitochondria isolated from 20 weeks DIO and control groups and thereafter a citrate synthase (CS) activity assay was performed on these mitochondria. RESULTS: After the 8 and 20 weeks diet, the DIOs had significantly increased intra-peritoneal fat mass, fasting plasma glucose and insulin levels, compared to their controls. Cytosolic WB analysis: The tp85, pp85 and pPKB/Akt levels were significantly higher in the DIOs in comparison to the controls after 8 weeks of diet. Furthermore, pBad and Bax expression were significantly elevated in these animals. After 20 weeks of diet, the DIOs had significantly decreased pp85, tPKB/Akt and pPKB/Akt levels. The tBad was significantly elevated, while the Bad phosphorylated over total expression (P/T) ratio was significantly decreased, in these animals. CS activity assay: CS activity was significantly decreased in the DIOs, versus the controls, at 20 weeks. Mitochondrial ETC WB analysis: The subunit expression in complexes I-III and V did not differ significantly after 8 weeks however, the expression was significantly lower in complexes I and II after 20 weeks. Interestingly, the complexes III and V expression was significantly elevated. Mitochondrial OXPHOS analysis: The ADP/O ratio with (1) glutamate or (2) palmitoyl-L- carnitine as substrate, showed a significant decrease in the DIOs at 20 weeks. Mitochondrial WB analysis: The pp85 subunit was significantly elevated in the control and DIO groups, exposed to insulin and ischemia, in comparison to the untreated controls. The Bcl-2 levels were significantly decreased in the insulin and ischemia DIOs, when matched against the untreated DIOs. The tBad expression did not differ significantly between the insulin and untreated controls, while the tBad was significantly augmented in the ischemia controls versus untreated controls. All significant differences were taken as p<0.05. CONCLUSION: The results indicate that the initial stage of diet-induced obesity is associated with cardioprotection as there is augmented PI3K/PKB/Akt pathway signalling and a decrease in apoptotic markers. In contrast, during the advanced stages of obesity a decreased activity in PI3K/PKB/Akt pathway is associated with myocardial apoptosis and decreased mitochondrial function and integrity.
AFRIKAANSE OPSOMMING: INLEIDING: Die meganisme verantwoordelik vir vetsug-verwante kardiomiopatieë is huidiglik nie bekend nie maar kardiale insulienweerstandigheid word geïmpliseer as een van die hoof bemiddelaars van vetsug-verwante hartsiektes. Verskeie studies het versteurings in die insulien-gemediëerde PI3K/PKB/Akt pad geassosieer met die bevordering van hierdie insulienweerstandigheid. Daarbenewens is dit getoon dat hierdie pad betrokke is in die regulering van miokardiale apoptose, wat op sy beurt geïmpliseer is in 'n aantal kardiovaskulêre siektes. Daar is tans min studies beskikbaar wat die vroeë en laat gevolge van obesiteit op die hart vergelyk. DOELWITTE: Om die vroeë en gevorderde stadiums van vetsug te vergelyk in terme van miokardiale (i) PI3K/PKB/Akt seintransduksie, (ii) apoptotiese seintransduksie en (iii) mitokondriale integriteit. Verder, het die studie ten doel om die kardiale mitokondriale (i) PI3K/PKB/Akt en (ii) apoptotiese seintransduksie en (iii) integriteit in die gevorderde stadiums van vetsug te bepaal. METODES: Manlike Wistar rotte is ewekansig toegewys aan óf 'n kontrole of dieet-geïnduseerde vetsug (DIO) groep. Kontroles is met 'n normale rotkos dieet en die DIO groep met 'n hoë kalorie dieet (normale rotkos aangevul met sukrose en kondensmelk) gevoed. Die dieet is vir 8 of 20 weke volgehou en daarna was die liggaamsgewig, intra-peritoneale vet massa, en vastende bloed glukose en insulien vlakke (insluitende intra-peritoneale glukose toleransie toets (IPGTT`s)) bepaal. Gevriesklampte harte van beide groepe is onderwerp aan sitosoliese WB-analise vir die PI3K p85 subeenheid, PKB / Akt, GSK-3α/β, Bad, Bax en Bcl-2. `n Fraksie van hierdie harte is ook onderwerp aan westerse klad analise (WK-analise) van die mitokondriale elektron vervoer ketting (EVK) komplekse (I-V). Daarna is bogenoemde proteïene ondersoek in mitokondrieë geïsoleer uit die 20 weke groep ná die toediening van insulien en die blootstelling van die harte aan iskemie. Die oksigraaf mitokondriale oksidatiewe fosforilering (OXPHOS) kapasiteit analise is dan op mitokondrieë van 20 weke DIO en kontrole groepe uitgevoer en daarna is 'n sitraatsintase (SS) aktiwiteitstoets gedoen. RESULTATE: Na die 8 en 20 weke dieet, het die intra-peritoneale vet massa, vastende plasma glukose en insulien vlakke in die DIOs aansienlik toegeneem, in vergelyking met hul kontroles. Sitosoliese WK-analise: Die tp85, pp85 en pPKB/Akt vlakke was beduidend hoër in die DIOs in vergelyking met die kontroles, na 8 weke van die dieet. Verder is die pBad en Bax vlakke beduidend verhoog in hierdie diere. Na 20 weke van die dieet, het die pp85, tPKB/Akt en pPKB/Akt vlakke beduidend afgeneem in die DIOs, in vergelyking met die kontroles. Die tBad was beduidend verhoog, terwyl die Bad verhouding van gefosforileerde oor die totale proteïen uitdrukking (P/T)-verhouding) beduidend verminder het in hierdie diere. SS aktiwiteitstoets: SS aktiwiteit is beduidend verminder in die DIOs, teenoor die kontroles, op 20 weke. Mitokondriale EVK WK-analise: Die subeenheid uitdrukking in komplekse I-III en V was nie beduidend verskillend na 8 weke nie. Na 20 weke egter, was die uitdrukking aansienlik laer in komplekse I en II. Interessant genoeg, is die uitdrukking aansienlik verhoog in komplekse III en V. Mitokondriale OXPHOS analise: Die ADP/O verhouding met (1) glutamaat of (2) palmitiel-L-karnitien as substraat, het beduidend afgeneem in die DIOs teen 20 weke. Mitokondriale WK-analise: Die pp85 subeenheid was beduidend verhoog in die kontrole en DIO groepe, blootgestel aan insulien en iskemie, in vergelyking met die onbehandelde kontroles. Die Bcl-2 vlakke was beduidend verminder in die insulien en isgemie DIOs, in vergelyking met onbehandelde DIOs. Die tBad uitdrukking het nie beduidend verskil tussen die insulien en onbehandelde kontroles nie, terwyl die tBad beduidend verhoog was in die isgemie kontroles versus onbehandelde kontroles. Alle beduidende verskille is geneem as p<0.05. GEVOLGTREKKING: Die resultate dui daarop dat die eerste fase van dieet-geïnduseerde obesiteit geassosieer is met kardiale beskerming want `n toename in PI3K/PKB/Akt seintransduksie en 'n afname in apoptotiese merkers is waargeneem. In teenstelling, in die gevorderde stadium van vetsug is daar 'n afname in aktiwiteit in die PI3K/PKB/Akt pad wat verband hou met verhoogde miokardiale apoptose en verminderde mitokondriale funksie en integriteit.
Konicki, Annette Jakubisin. „Women’s Knowledge of Cardiovascular Risk Factors, Level of Self-Nurturance and Participation in Heart-Healthy Behaviors: A Dissertation“. eScholarship@UMMS, 2009. https://escholarship.umassmed.edu/gsn_diss/11.
Bücher zum Thema "Heart Diseases Prevention":
C, Catford J., Cleeman J. I und Royal Society of Medicine (Great Britain), Hrsg. Primary health care and CHD prevention. London: Royal Society of Medicine Services, 1991.
Jackson, Gordon. The healthy heart. London: Salamander, 1986.
Nora, James J. Cardiovascular diseases: Genetics, epidemiology, and prevention. New York: Oxford University Press, 1991.
Graham, Jackson. Heart health. 4. Aufl. London: Class Health, 2009.
Saxena, Shikha. Phytochemicals and heart diseases: Causation and prevention. New Delhi: Mittal Publications, 2011.
B, Clayman Charles, und American Medical Association, Hrsg. Your heart. Pleasantville, N.Y: Reader's Digest Association, 1989.
Baum, Seth J. The total guide to a healthy heart: Integrative strategies for preventing and reversing heart disease. New York: Kensington, 1999.
Ontario. Chief Medical Officer of Health. Promoting heart health. [Toronto, Ont: The Ministry, 1993.
Zaret, Barry L. Heart care for life: Developing the program that works best for you. New Haven: Yale University Press, 2006.
Baum, Seth J. The total guide to a healthy heart. New York: Kensington, 2000.
Buchteile zum Thema "Heart Diseases Prevention":
de Melo Barbosa, Marcia, Maria do Carmo Pereira Nunes und Regina Müller. „Rheumatic Heart Disease: A Neglected Heart Disease“. In Prevention of Cardiovascular Diseases, 143–57. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22357-5_15.
Puddu, P., und M. Muscari. „Therapy versus prevention of coronary heart disease“. In Atherosclerosis and Cardiovascular Diseases, 163–70. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3205-0_20.
Ilkhanoff, Leonard, Alan H. Kadish und Jason T. Jacobson. „Non-antiarrhythmic Drugs in Sudden Death Prevention“. In Electrical Diseases of the Heart, 525–41. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4978-1_34.
Tung, Patricia, und Peter J. Zimetbaum. „Non-surgical Treatment and Prevention of Atrial Fibrillation“. In Electrical Diseases of the Heart, 543–59. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4978-1_35.
Kosinski, Andrzej S. „Clinical Trials in Sudden Cardiac Death Prevention: Principles and Endpoints“. In Electrical Diseases of the Heart, 487–93. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4978-1_31.
Mastorci, Francesca, Irene Traghella, Laura Sabatino, Alessandro Pingitore, Rudina Ndreu und Cristina Vassalle. „Oxidative Stress and Cardiovascular Risk and Prevention in Children and Adolescents“. In Oxidative Stress in Heart Diseases, 3–18. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-8273-4_1.
Lee, Hon-Chi, und Kristin T. L. Huang. „Clinical Role of Antiarrhythmic Drugs in the Prevention of Sudden Death“. In Electrical Diseases of the Heart, 501–24. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4978-1_33.
Nof, Eyal, Michael Glikson, David Luria, Joseph Gard und Paul A. Friedman. „Beyond Sudden Death Prevention: Minimizing ICD Shocks and Morbidity, and Optimizing Efficacy“. In Electrical Diseases of the Heart, 621–47. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4978-1_40.
Miller, Henry S. „Exercise for Prevention and Treatment of Coronary Heart Disease“. In Exercise for Preventing Common Diseases, 69–73. Tokyo: Springer Japan, 1999. http://dx.doi.org/10.1007/978-4-431-68511-1_9.
Epstein, F. H. „Prevention of coronary heart disease - links with other chronic disorders“. In Atherosclerosis and Cardiovascular Diseases, 157–62. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3205-0_19.
Konferenzberichte zum Thema "Heart Diseases Prevention":
Barbey, Alex, und Frano Mika. „Prevention of Heart Attacks and Other Cardiovascular Diseases in the Oil and Gas Industry“. In SPE International Conference on Health, Safety, and Environment. Society of Petroleum Engineers, 2014. http://dx.doi.org/10.2118/168311-ms.
Mesihović-Dinarević, Senka. „UPDATE IN DIAGNOSTICS CARDIOLOGY“. In International Scientific Symposium “Diagnostics in Cardiology and Grown-Up Congenital Heart Disease (GUCH)”. Academy of Sciences and Arts of Bosnia and Herzegovina, 2021. http://dx.doi.org/10.5644/pi2021.199.02.
Poniewierski, M., M. Barthels und H. Poliwoda. „THE SAFETY AND EFFICACY OF A LOW MOLECULAR WEIGHT HEPARIN (FRAGMIN) IN THE PREVENTION OF DEEP VEIN THROMBOSIS IN MEDICAL PATIENTS: A RANDOMIZED DOUBLE-BLIND TRIAL“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643224.
A Concept, Life-Style:. „Tailoring Motivational Mechanisms to Engage Teenagers in Healthy“. In Applied Human Factors and Ergonomics Conference. AHFE International, 2021. http://dx.doi.org/10.54941/ahfe100499.
Babalola, R. O., O. A. Fagade und P. A. AJAYI. „Heart Disease Prevention In The Workplace: A Case Study“. In SPE International Conference on Health, Safety and Environment in Oil and Gas Exploration and Production. Society of Petroleum Engineers, 2000. http://dx.doi.org/10.2118/61022-ms.
C., Sujatha, und Anitha R. „Preventing Heart Disease and Stroke in Cardiovascular Diabetics“. In International Conference on Computer Applications — Computer Applications - I. Singapore: Research Publishing Services, 2010. http://dx.doi.org/10.3850/978-981-08-7618-0_1464.
„Modernising Morbidity and Mortality: Features of Cardiovascular Diseases of the Population of the RSFSR in 1960s“. In XII Ural Demographic Forum “Paradigms and models of demographic development”. Institute of Economics of the Ural Branch of the Russian Academy of Sciences, 2021. http://dx.doi.org/10.17059/udf-2021-1-1.
Holm, Jukka, Reijo Laaksonen, Paul Dendale, Cindel Bonneux und Martijn Scherrenberg. „Creating Audio-Visual Content for a Personalized Prevention Programme in Coronary Heart Disease“. In 2022 26th International Conference Information Visualisation (IV). IEEE, 2022. http://dx.doi.org/10.1109/iv56949.2022.00070.
Al-Salamah, Mashail, und Saad Amin. „Heart Disease Diagnosis Using Reconstructive Radial Basis Function Networks with Overlapping Prevention Method“. In 5th EAI International Conference on Wireless Mobile Communication and Healthcare - "Transforming healthcare through innovations in mobile and wireless technologies". ICST, 2015. http://dx.doi.org/10.4108/eai.14-10-2015.2261993.
Asmare, Melkamu, Frehiwot Woldehanna, Luc Janssens und Bart Vanrumste. „Automated Rheumatic Heart Disease Detection from Phonocardiogram in Cardiology Ward“. In Special Session on Machine Learning and Deep Learning Improve Preventive and Personalized Healthcare. SCITEPRESS - Science and Technology Publications, 2020. http://dx.doi.org/10.5220/0009367108390844.
Berichte der Organisationen zum Thema "Heart Diseases Prevention":
FEDOTKINA, S. A., O. V. MUZALEVA und E. V. KHUGAEVA. RETROSPECTIVE ANALYSIS OF THE USE OF TELEMEDICINE TECHNOLOGIES FOR THE PREVENTION, DIAGNOSIS AND TREATMENT OF HYPERTENSION. Science and Innovation Center Publishing House, 2021. http://dx.doi.org/10.12731/978-0-615-67320-2-4-22.
AlBakri, Aref, Auswaf Ahsan, Manoj Vengal, KR Ashir, Abdul Majeed und Hanan Siddiq. Antibiotic Prophylaxis before Invasive Dental Procedures for Patients at High-Risk of Infective Endocarditis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Juli 2022. http://dx.doi.org/10.37766/inplasy2022.7.0011.
Liu, Mengnan, Raoqiong Wang, Ziyi Li, Maryam Mazhar, Gang Luo und Sijin Yang. Danshen decoction in the treatment of heart failure: a systematic review and meta-analysis protocol of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Juli 2022. http://dx.doi.org/10.37766/inplasy2022.7.0107.
Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel und Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), März 2021. http://dx.doi.org/10.23970/ahrqepctb38.
Wei, Dongmei, Yang Sun und Hankang Hen. Effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention: A protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0080.
Xie, Bo, Xiaojiao Cui, Hao Wang, Fuqiang Liu, Fang Qin, Jun Zhang und Xiaoqing Yi. Prevention of contrast-induced acute kidney injury by probucol combined with hydration in patients with coronary heart disease: a systematic review and meta analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Mai 2022. http://dx.doi.org/10.37766/inplasy2022.5.0157.
Gindi, Renee. Health, United States, 2019. Centers for Disease Control and Prevention (U.S.), 2021. http://dx.doi.org/10.15620/cdc:100685.
Cohen, Yuval, Christopher A. Cullis und Uri Lavi. Molecular Analyses of Soma-clonal Variation in Date Palm and Banana for Early Identification and Control of Off-types Generation. United States Department of Agriculture, Oktober 2010. http://dx.doi.org/10.32747/2010.7592124.bard.
Totten, Annette, Dana M. Womack, Marian S. McDonagh, Cynthia Davis-O’Reilly, Jessica C. Griffin, Ian Blazina, Sara Grusing und Nancy Elder. Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication. Agency for Healthcare Research and Quality, Dezember 2022. http://dx.doi.org/10.23970/ahrqepccer254.